ロード中...

Nutlin-3 Enhances Sorafenib Efficacy in Renal Cell Carcinoma

The renal cell carcinoma (RCC) is one of the top ten cancers in USA. The renal tumors are highly angiogenic and are resistant to conventional interventions, particularly radiotherapy. The advent of multispecific tyrosine kinase inhibitor sorafenib has improved the progression-free survival in RCC, b...

詳細記述

保存先:
書誌詳細
主要な著者: Vatsyayan, Rit, Singhal, Jyotsana, Nagaprashantha, Lokesh Dalasanur, Awasthi, Sanjay, Singhal, Sharad S.
フォーマット: Artigo
言語:Inglês
出版事項: 2011
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4153352/
https://ncbi.nlm.nih.gov/pubmed/22006587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mc.20875
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!